Tirzepatide 30mg from Mile High Compounds achieved 99.934% purity in this independent RP-HPLC analysis conducted by Kovera Labs on March 9, 2026. The tested quantity of 34.89mg exceeds the stated 30mg label claim by 16.3%, demonstrating proper formulation accuracy.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its role in metabolic regulation, weight management, and glycemic control. A purity level of 99.934% indicates minimal contamination and high-grade synthesis quality. Heavy metal screening confirmed negative results for lead, cadmium, arsenic, and mercury.
The full certificate of analysis is available for download on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.